Published in J Clin Microbiol on August 10, 2011
The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol (2012) 1.24
Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study. J Clin Microbiol (2013) 1.05
Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping. J Clin Microbiol (2013) 0.95
Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One (2014) 0.92
Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology. Open Virol J (2012) 0.91
Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing. PLoS One (2013) 0.81
Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80
Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping. Cancer Med (2012) 0.79
Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infect Dis (2013) 0.77
The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results. PLoS One (2017) 0.75
Human papilloma virus-16 causing giant condyloma acuminata. J Surg Case Rep (2014) 0.75
Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay. J Clin Microbiol (2014) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Chapter 1: HPV in the etiology of human cancer. Vaccine (2006) 6.61
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol (1999) 6.45
Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis (2005) 3.84
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55
A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60
HPV testing in primary screening of older women. Br J Cancer (1999) 2.44
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev (2008) 2.20
Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol (2006) 2.05
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol (2006) 1.96
Global proficiency study of human papillomavirus genotyping. J Clin Microbiol (2010) 1.78
Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J Clin Microbiol (2007) 1.64
Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol (2008) 1.59
Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev (2006) 1.47
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer (2007) 1.30
WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine (2008) 1.28
Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev (2006) 1.28
Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol (2007) 1.20
Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol (2006) 1.19
Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol (1996) 1.14
Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 korean women determined by DNA chip. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol (2008) 1.04
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness. Int J Cancer (2009) 0.99
Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int J Cancer (2010) 0.96
Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination. Clin Exp Immunol (2007) 0.96
Monitoring HPV vaccination. Vaccine (2008) 0.81
Structure of simian virus 40 at 3.8-A resolution. Nature (1991) 5.96
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94
DNA sequence comparison between two tissue-specific variants of the autonomous parvovirus, minute virus of mice. Nucleic Acids Res (1985) 2.24
A precise map of splice junctions in the mRNAs of minute virus of mice, an autonomous parvovirus. J Virol (1986) 2.11
A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun (1995) 1.91
A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol (1991) 1.77
Characterization of the cell type-specific determinant in the genome of minute virus of mice. J Virol (1988) 1.59
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol (1998) 1.48
Ribotyping of Pseudomonas aeruginosa: discriminatory power and usefulness as a tool for epidemiological studies. J Clin Microbiol (1993) 1.38
Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect Immun (1997) 1.38
Development of polymerase chain reaction assays for detection of Listeria monocytogenes in clinical cerebrospinal fluid samples. J Clin Microbiol (1992) 1.25
Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis (2000) 1.16
Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol (1991) 1.10
Conserved anterior boundaries of Hox gene expression in the central nervous system of the leech Helobdella. Dev Biol (1997) 1.05
The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun (1999) 0.95
Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping. J Clin Microbiol (2013) 0.95
Expression of human papillomavirus 16 E2 protein in Schizosaccharomyces pombe delays the initiation of mitosis. Oncogene (1999) 0.94
Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia (1993) 0.93
Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Haematol (1990) 0.92
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis (2010) 0.91
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol (2012) 0.90
Involvement of connexin 43 in meiotic maturation of bovine oocytes. Reproduction (2001) 0.89
The mismatched nucleotides in the 5'-terminal hairpin of minute virus of mice are required for efficient viral DNA replication. J Virol (1995) 0.86
[Bilateral conjunctivo-palpebral tumor in an immunocompetent man cause by human papilloma virus]. Klin Monbl Augenheilkd (1994) 0.82
The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1. AIDS Res Hum Retroviruses (1998) 0.79
Ornithodoros moubata: spermateleosis and secretory activity of the sperm. Exp Parasitol (1985) 0.79
Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash. Clin Infect Dis (1995) 0.78
Single tube competitive PCR for quantitation of CMV DNA in the blood of HIV+ and solid organ transplant patients. J Virol Methods (1998) 0.78
Case report: human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient. J Med Virol (2008) 0.77
Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF. Eur Neurol (1999) 0.77
Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease. Leuk Lymphoma (1992) 0.75
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system. J Neurovirol (1999) 0.75
Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabet Med (2009) 0.75
[A primer on the management of antiviral resistance in chronic hepatitis B]. Rev Med Suisse (2009) 0.75
Origin of segmental identity in the development of the leech nervous system. Development (1991) 0.75
Bilateral MALT-type ocular adnexal lymphoma with marginal zone lymphoma leukaemic cells and ophthalmological diffuse large B cell lymphoma. Br J Ophthalmol (2008) 0.75
[An update on hepatitis E]. Rev Med Suisse (2013) 0.75
Giant warts in a kidney transplant patient: regression with sirolimus. Br J Dermatol (2010) 0.75
Adenovirus-mediated gene transfer into selected liver segments using a vascular exclusion technique. Eur Surg Res (2002) 0.75
A mutagenic PCR identifies isolates of Borrelia garinii responsible for Lyme borreliosis. FEMS Microbiol Lett (2000) 0.75